Mitochondria fuse together to transfer genetic information and promote mutual repair through content exchange. Tethering and fusion of the mitochondrial outer membrane is mediated by mitofusins (Mfn) 1 and 2 and is essential both for embryonic development [1] [2] [3] and tissue homeostasis [4] [5] [6] . The multiple mutations that provoke MFN2 dysfunction can cause the untreatable neurodegenerative condition CMT2A 7 . The obligate initial step in mitochondrial fusion is formation of mitochondria-mitochondria tethers. Mitofusins on different mitochondria undergo GTPase-independent trans-dimerization through the anti-parallel binding of their extended C-terminal α -helical domains 8 . Mitofusins are conventionally thought to exist in a constitutively 'active' extended molecular conformation that is permissive of tethering; however, there is a lack of specific contextual data on other possible structural determinants of mitofusin-mediated mitochondrial tethering. Here, on the basis of domain similarity between human mitofusins and the prototypical dynamin superfamily protein bacterial dynamin-like protein (DLP) 9 , we posit that mitofusins can adopt a more folded molecular conformation. Such conformational plasticity could be experimentally and therapeutically manipulated to enhance or suppress mitochondrial tethering and subsequent tethering-dependent organelle fusion.
Conformational malleability of MFN2
MFN1 and MFN2 share an N-terminal GTPase domain followed by a first coiled-coil heptad-repeat region (HR1), two adjacent small transmembrane domains and a second, C-terminal, coiled-coil heptadrepeat region (HR2) (Fig. 1a) . Amino-acid conservation is highest in the GTPase, transmembrane and HR2 regions (Extended Data  Fig. 1a ). HR2 domains that extend from MFN molecules on different mitochondria dimerize to tether the organelles 8 ( Fig. 1b) and HR2 can also bind HR1 (ref. 10) . Using the crystal structure of bacterial DLP 9 to model the structure of MFN2, we refined the identities of HR2 amino acids that mediate intermolecular HR2-HR2 tethering 8 (Extended Data Fig. 1b and Supplementary Video 1). We also predicted that these same amino acids mediate the intramolecular antiparallel binding of HR2 to HR1 (Fig. 1c , Extended Data Fig. 1c and Supplementary Video 2). Local unfolding and bending of the HR1 α -helix at amino acids 384-387 (Arg-Glu-Gln-Gln) constrains the HR2 binding region to within the core MFN2 globular structure. This restrains HR2, which we predict to bend at amino acids 712-715 (Gln-Glu-Ile-Ala) (Figs 1c, d and Supplementary Video 3). This configuration would not be conducive for mitochondrial tethering, which requires the cytosolic extension of HR2 ( Fig. 1d and Supplementary Video 4).
Manipulating fusion with HR1 minipeptides
We examined the functional importance of intramolecular binding between MFN2 HR1 and HR2 by introducing a recombinant MFN2 HR1 minipeptide fragment on an adenovirus vector, containing the sequences predicted to mediate intramolecular HR1-HR2 binding (MP-HR1) into mouse embryonic fibroblasts (MEFs). According to our proposed mechanism, the competition for intramolecular HR1-HR2 interactions by free HR1 domains should unfold the protein, extend the terminal HR2 arm and promote mitochondrial tethering or fusion. Indeed, MP-HR1 increased the mitochondrial aspect ratio (the ratio of the mitochondrial major axis dimension (or length) to minor axis dimension (or width), reflecting fusion) in both wild-type and Mfn2-null 11 MEFs (Fig. 1e) Article reSeArcH
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To localize HR1-HR2 binding domains, we used an adenovirus vector to express minipeptides that flank the HR1 Arg-Glu-Gln-Gln bend. These were minipeptide 1 (MP1, a minipeptide made up of residues 367-384 of MFN2), MP2 (made up of residues 398-418) and MP3 (made up of residues 428-448). We also engineered mutated minipeptides, substituting the centrally positioned leucine residues for either glycine residues (to increase flexibility in the secondary structure) or proline residues (to break the α -helix). MP3 and its Gly-and Pro-substituted mutant counterparts did not affect mitochondrial aspect ratio, whereas MP1
Gly and MP2 Gly (the glycine-substituted minipeptide counterparts of MP1 and MP2) consistently had opposing effects on mitochondrial morphology (Extended Data Fig. 2 ).
MP-HR1, MP1
Gly and MP2 Gly all altered the mitochondrial aspect ratio in MEFs that expressed Mfn1 or Mfn2 in any combination, but not in MEFs that completely lack mitofusins (Extended Data Fig. 2a) . Thus, MFN2 HR1-derived minipeptides modulate mitochondrial fusion, mediated by either Mfn1 or Mfn2. MP1
Gly and MP2
Gly did not adversely affect mitochondrial polarization status (Extended Data Fig. 2b ), or Parkin recruitment and mitophagy induced by mitochondrial uncoupling (Extended Data Fig. 2c ), which are also affected by mitofusins 12, 13 . According to our molecular model of MFN2, the fusion-promoting MP1
Gly should bind amino acids 716-736, near to the MFN2 C terminus (Fig. 2a) . Competition for intramolecular HR1-HR2 binding by the peptide would release HR2 from its HR1 anchor and permit it to unfold into a cytosol-extended conformation (Fig. 2b) . By contrast, the fusion-suppressing MP2
Gly should bind HR2 at amino acids 682-701 ( Fig. 2a) , thus interrupting the HR2-HR2 interactions that are essential for transmitochondrial tethering (Fig. 2b) .
We studied our minipeptides after synthesizing them as cellpermeant C-terminal TAT 47-57 (residues 47-57 of the HIV transactivator protein, which are able to directly transport through the cell membrane) conjugates. The fusion-mediated mixing of mitochondrial contents 14 was more than doubled by the addition of 1 μ M TAT-MP1
Gly for 6 h, whereas 1 μ M TAT-MP2 Gly completely suppressed mitochondrial fusion (Fig. 2c) . The mitochondrial aspect ratio changed in parallel ( 
HR1 minipeptides alter MFN2 conformation
Additional studies validated the conformational-shift mechanism of minipeptide action: FITC-labelled TAT-conjugated minipeptides decorated mitochondria in normal cells, but not in cells that lacked mitofusins (Mfn1/Mfn2 double-knockout MEFs) (Fig. 3a) . The binding of minipeptides to recombinant Mfn2 was positively cooperative (Fig. 3b) , consistent with the destabilization of highly folded Mfn2 by MP1
Gly and thus facilitating the binding of MP2 Gly to newly extended C-terminal HR2 domains. We demonstrated that TAT-MP1
Gly promoted MFN2 HR2 unfolding and extension by showing that it accelerated C-terminal-directed proteolytic digestion of MFN2 (TAT-MP2
Gly had the opposite effect) (Fig. 3c) . Finally, using Förster resonance energy transfer (FRET), we determined that TAT-MP2 Gly promotes a more folded conformation of human MFN2, tagged at the N terminus with mCerulean1 and the C terminus with mVenus1 (Fig. 3d) . Collectively, the data in Figs. 2, 3 demonstrate that the effects of MFN2 HR1-derived minipeptides on mitochondrial fusion derive from their ability to promote or suppress the unfolding of Mfn2 and the extension of its HR2 domain.
Correcting mitochondrial fusion defects
Pathological mitochondrial fragmentation in CMT2A is caused by nonsense or damaging non-synonymous MFN2 mutations 7 . We simulated compound nonsense MFN2 mutations seen in autosomal recessive CMT2A by Mfn2 gene ablation. TAT-MP1
Gly treatment for 24 h normalized the mitochondrial aspect ratio of Mfn2-knockout MEFs (Extended Data Fig. 5 ). However, after the adenoviral introduction of mouse Mfn2 K109A (a GTPase-defective mutant), TAT-MP1
Gly did not correct mitochondrial fragmentation in Mfn1/Mfn2-null MEFs 15 (although mitochondrial clumping suggested enhanced mitochondria-mitochondria tethering in the absence of organelle fusion) (Extended Data Fig. 6 ). An Mfn2 amino-acid mutant with normal fusion activity but defective Parkin binding (T111 and S442 alanine mutants 12, 13 ) responded similarly to wild-type Mfn2. These findings hint at the therapeutic potential of compelling endogenous normal mitofusins into their active, unfolded conformation in order to overcome dominant inhibition by GTPase-defective MFN2 mutants in diseases like CMT2A. To test this notion, we used MEFs that express the CMT2A-causative mutant human MFN2 T105M (refs 16,17) as a conditional flox/stop (fl/st) transgene (Figs 4a, b) .
Mitochondria of MFN2
T105M fl/st MEFs fragmented and depolarized after adenoviral-Cre application (Figs 4a, c ), but addition of 1 μ M TAT-MP1
Gly rapidly reversed mitochondrial abnormalities. By contrast, suppressing mitochondrial fusion with TAT-MP2
Gly aggravated mitochondrial dysmorphology and exacerbated the mitochondrial depolarization that was induced by MFN2 T105M (Fig. 4c) . Parallel adenoviral expression of wild-type MFN2 at more than twice the levels of MFN2 T105M (fivefold versus twofold) provoked neither mitochondrial nor cellular toxicity (Extended Data Fig. 7 ).
Repairing neuronal CMT2A pathology
As neurons are the cell type most relevant to CMT2A, we examined the effects of TAT-MP1
Gly on cultured rat neurons bearing the 
GTPase-defective MFN2
K109A mutant and found that its addition corrected mitochondrial pathology (Extended Data Fig. 8 ). We tested fusion-promotion further through the conformational manipulation of mitofusins in cultured neurons from mouse pups carrying the conditional MFN2 T105M fl/st expression allele, a 'disease in a dish' model of a naturally occurring human CMT2A mutation (Fig. 5a) . Live-cell analysis demonstrated that adeno-Cre induction of MFN2 T105M (Fig. 5b) evoked widespread neuronal mitochondrial dysmorphology, with fragmentation and partial depolarization (Fig. 5c, d and Extended Data Fig. 9 ). Mitochondrial clumping was prevalent after induction of MFN2
T105M
, which was consistent with the interruption of GTP-dependent mitochondrial fusion but preserved GTPaseindependent mitochondrial tethering (Fig. 5d) . Addition of 1 μ M TAT-MP1
Gly for 24 h largely reversed these abnormalities (Fig. 5c, d and Extended Data Fig. 9 ).
Discussion
By combining computational modelling of the structure of mitofusins (based on the crystal structure of bacterial DLP) with functional interrogation of intramolecular mitofusin interactions using engineered competing peptides, we provide evidence for two functionally distinct conformational states of mammalian mitofusins. The contrasting effects of the engineered minipeptides on mitochondrial fusion were linked to their reciprocal modulation of mitofusin HR1 folding and unfolding.
The canonical representation of MFN1 and MFN2, as described by Chan and colleagues 8 , is of a protein anchored to the outer mitochondrial membrane by a transmembrane domain, with N-and C-terminal structures extending perpendicularly into the cytosol. This resembles an unfolded MFN conformation that is optimal for mitochondrial tethering and therefore permissive of fusion. Our model suggests, Author Information Reprints and permissions information is available at www.nature.com/reprints. The authors declare competing financial interests: details are available in the online version of the paper. Readers are welcome to comment on the online version of the paper. Correspondence and requests for materials should be addressed to G.W.D. (gdorn@wustl.edu).
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however, that the core globular MFN molecule is adherent to the mitochondrial membrane. Moreover, in the resting state, or that nonpermissive to tethering, the HR2 domain is restrained by antiparallel intramolecular binding to HR1; destabilization of this binding allows HR2 to unfold and extend into the cytosol, into a tethering-permissive state.
Conformational plasticity has important implications for the mitochondrial gap-distance that is maintained by Mfn-Mfn tethering, variously reported as 78 ± 37 Å (ref. 18 ) or 159 ± 30 Å (ref. 8). On the basis of a calculated HR2 arm-length of 150 Å that begins from the putative Gly 'shoulder' at the C terminus of the transmembrane domain (Gly623 of MFN1; Gly642 of MFN2), and accounting for the 60-amino-acid overlap of the HR2-HR2 homodimer, the maximal tethered mitochondrial gap distance according to our model would be 245 Å. However, flexing of each MFN HR2 at its shoulder would retract tethered mitochondria (Fig. 5e) , narrowing the gap between them. The crystal structure of bacterial DLP indicates that the binding of GTP promotes DLP dimerization at GTP-binding domains 9 . The same GTPdependent event for MFN2 would, with concomitant trans-dimerization of HR2 domains, create a multimeric molecular patch between two adjoining mitochondria, facilitating GTP-dependent outer-membrane fusion (Fig. 5e) . Thus, MFN structural malleability may be important not only to initiate tethering, but to facilitate the progression from organelle tethering to apposition and then union.
In designing our conformation-altering minipeptides, we contemplated the difficulty of destabilizing a constrained MFN structure using peptides identical to the parent HR1 domains with which they were intended to compete. Accordingly, we substituted rotational Gly residues for Leu residues facing away from the putative HR1-HR2 (MP1 Gly ) and HR2-HR2 (MP2 Gly ) interaction sites. The importance of minipeptide flexibility at these sites was confirmed by their functional inactivation by substitution with rigid proline residues at the same positions.
Our fusogenic cell-permeant peptide, TAT-MP1 Gly , reversed mitochondrial dysmorphology and depolarization both in otherwise normal MEFs and in cultured neurons expressing either the artificial GTPase-deficient Mfn2 K109A mutant or the naturally occurring human CMT2A GTPase mutant, MFN2
T105M
. Because TAT-MP1 Gly did not correct the mitochondrial pathology induced by Mfn2 K109A in mitofusin-null cells, we conclude that rescue of the in vitro CMT2A models is due to enhanced mitochondrial tethering and fusion mediated by endogenous normal Mfn1 and Mfn2. Most CMT2A mutations, including MFN2 T105M , are autosomal dominant-patients have one mutant MFN2 allele, one normal MFN2 allele, and two normal MFN1 alleles 7 . Thus, rather than relying exclusively on genetic engineering to correct or silence MFN2 gene mutations, pharmacologically unfolding endogenous normal mitofusins to promote mitochondrial tethering and enhance fusion could prove beneficial in CMT2A and pathophysiologically related diseases.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper.
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MethOdS
Cell lines. Wild-type MEFs were prepared from embryonic age (E)10.5 C57BL/6 mouse embryos. SV-40 T-antigen-immortalized Mfn1-null (CRL-2992), Mfn2-null (CRL-2993) and Mfn1/Mfn2-double-null MEFs (CRL-2994), originally developed by D. Chan 2 , were purchased from ATCC. MEFs conditionally expressing the human Mfn2 T105M mutation were prepared from E10.5 embryos of C57BL/6-Gt(ROSA)26Sor[tm1(CAG-MFN2*T105M)Dple]/J mice purchased from The Jackson Laboratory (Stock No: 025322). All cell lines were tested for mycoplasma and found to be mycoplasma-free. MEFs were maintained in DMEM containing 4.5 g l −1 glucose (or galactose, where specified) supplemented with 10% fetal bovine serum, 1× nonessential amino acids, 2mM l-glutamine, 100 U ml −1 penicillin and 100 μ g ml −1 streptomycin. Cultured mouse neurons. Hippocampal and cortical neurons were prepared from individual postnatal day (P)0-1 mouse pups using a modification of methods described for rat neuronal culture 19 . Mouse pups were genotyped after neuron preparation to determine the presence or absence of the MFN2 T105M transgene; neurons derived from mice lacking the transgene were designated as normal controls. After 10 days of culture, neurons were infected with Adeno-Cre or Adeno-β gal control (50 MOI). After 72 h, 1 μ M TAT-MP1
Gly or vehicle was added. Live neurons were imaged as described below. Cultured rat motor neurons. Motor neurons were isolated from E17 SpragueDawley rats and cultured as described 20 . After 10 days in culture, neurons were infected twice, 8 h apart, with 50 MOI of adenoviral wild-type Mfn2 or Mfn2 K109A and treated with 1 μ M TAT-MP1
Gly or control TAT peptide for 24 h. The mitochondria of formalin-fixed neurons were labelled with anti-TOM20 (Santa Cruz Biotechnology); neurons were stained with Hoechst 33342. Laser confocal imaging using a 63× oil objective was used to identify isolated mitochondria to determine aspect ratio. Adenoviral stocks. Empty adenovirus (Ad-CMV-Null; #1300) and adenovirus expressing β -galactosidase (Ad-CMV-b-Gal; #1080) or Cre recombinase (Ad-CMV-iCre; #1045) were obtained from Vector Biolabs. Adenoviral expression vectors for human Mfn2 HR1 and the minipeptides and their Gly-or Pro-mutant counterparts were generated and amplified using standard methods. Adenoviral vectors at an MOI of 100 were added to MEFs when at 50% confluence. Adeno-PA-GFP (mitoGFP) and adeno-mitoDsRed2 (both from SignaGen Laboratories) were added to cultured mouse neurons at an MOI of 10 or 50. Antibodies and immunoblotting. Anti-Mfn1 (sc-50330) and anti-Opa1 (sc393296) were obtained from Santa Cruz. Anti-Mfn2 (ab56889), anti-Drp1 (ab56788), and anti-GAPDH (ab8245) were obtained from Abcam. Anti-MFF (17090-1-ap) was obtained from Proteintech. Cell-protein lysates were sizeseparated on 10% SDS-PAGE gels, transferred onto nylon membranes, incubated with primary antibody and detected with peroxidase-conjugated anti-mouse secondary antibody (Cell Signaling, 7076S, 1:4,000) or goat anti-rabbit secondary antibody (Thermo Scientific, 31460, 1:4,000) using enhanced chemiluminescence substrate (PerkinElmer, NEL105001EA) on a Li-COR Odyssey system for digital acquisition. Gel source data are shown in Supplementary Fig. 1 Carboxypeptidase protection assay of Mfn2. Mitochondrial membranes were prepared 6 from mouse hearts overexpressing human Mfn2 13 and digested with 200 ng ml −1 each of carboxypeptidases A and B (Sigma-Aldrich) for increasing times at room temperature, followed by immunoblotting using an antibody (Abcam ab56889) specific to human Mfn2 HR2. Live-cell imaging. MEFs or neurons were grown on chamber slides and infected with recombinant adenovirus for 48-72 h unless otherwise indicated. MEFs were stained with MitoTracker Green (200 nM, Invitrogen M7514) and Hoechst (10 mg ml −1 , Invitrogen H3570), with or without tetramethylrhodamine ethyl ester (TMRE; 200 nM, Invitrogen T-669), which stains normally polarized mitochondria. Neuronal mitochondria were labelled with adenoviralexpressed mitoGFP plus TMRE, or with adeno-mitoDsRed for time-lapse studies. Cover slips were loaded onto a chamber (Warner instrument, RC-40LP) in modified Krebs-Henseleit buffer (138 mM NaCl, 3.7 mM KCl, 1.2 mM KH 2 PO 4 , 15 mM Glucose, 20 mM HEPES and 1 mM CaCl 2 ) at room temperature and visualized on a Nikon Ti Confocal microscope equipped with a 60× 1.3 NA oil-immersion objective. For mitophagy studies, MEFs were stained with MitoTracker Green and transfected with mCherry-Parkin on an adenovirus vector or stained with LysoTracker Deep Red (50 nM, Invitrogen L-7528); carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP, 10 μ M for 1 h) was applied as a positive control. Mitochondrial fusion was measured 2 and 6 h after the PEG-mediated cell fusion of MEFs treated 48 h previously with adenovirus-transfected mitoGFP or adeno-mitoDsRed 14 . Laser confocal fluorescence was excited with 561 nm (for MitoTracker Green, GFP, FITC), 637 nm (for TMRE, LysoTracker Red, mCherry-Parkin, MitoTracker Orange) or 408 nm (for Hoechst) laser diodes.
Image analysis. Mitochondrial aspect ratio was calculated using automated edge detection and Image J software as described 6 . Mitochondrial depolarization was calculated as the percentage of green mitochondria visualized on MitoTracker Green and TMRE merged images, expressed as green/(green + yellow mitochondria) × 100. Parkin aggregation was calculated as the percentage of cells with mitochondrial clumping of mCherry-Parkin 6 . Lysosomal engulfment of mitochondria was identified by the co-localization of LysoTracker Red and MitoTracker Green 6 . TAT-minipeptide design, synthesis and use. We designed three polypeptides derived from MFN2: two from the HR1 region flanking its REQQ bend and one from the adjacent C-terminal area between HR1 and the transmembrane domain. Since these peptides are derived from α -helical domains, we attempted to conserve their secondary structure by maintaining a length of ~ 20 amino acids, which was predicted to create a stable α -helix of about five turns. We considered that the native ~ 20 amino acid polypeptides might not effectively compete with the endogenous HR1-HR2 interactions, as each represents only a portion of the overall HR1-interacting domain. We therefore generated two analogues for each of the three polypeptides, substituting the mid-peptide Leu residues for either Gly or Pro. We predicted that substituting Gly for the central Leu residues would increase the rotational flexibility of the peptide and enhance its ability to compete for, and interfere with, endogenous inter-domain interactions in intact Mfn2. Conversely, we reasoned that peptides in which Pro was substituted for the central Leu residue would be less active as the α -helix would be kinked, thus limiting competition for endogenous interactions. The nine polypeptides were expressed using adenovirus as mini-genes for screening and initial characterization. The two biologically active polypeptides, MFN2 MP1
